Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Google Shows AI Can Predict Lung Cancer from CT Scans

By HospiMedica International staff writers
Posted on 01 Jun 2019
Google LLC (Mountain View, CA, USA) has shared new research demonstrating how artificial intelligence (AI) can predict lung cancer to boost the chances of survival for people at risk across the world.

Since 2017, Google has been exploring how AI can be used to address the challenges in screening people at a high-risk for lung cancer with lower dose CT screening that leads to unclear diagnosis, subsequent unnecessary procedures, and financial costs. More...
Google used advances in 3D volumetric modeling along with datasets from its partners for modeling lung cancer prediction and laying the groundwork for future clinical testing.

Generally, radiologists go through hundreds of 2D images within a single CT scan with cancer being miniscule and hard to spot. Google researchers created a model that can generate the overall lung cancer malignancy prediction (viewed in 3D volume) as well as identify subtle malignant tissue in the lungs (lung nodules). The model can also factor in information from previous scans, which can be useful in predicting lung cancer risk as the growth rate of suspicious lung nodules can be an indicator of malignancy.

The researchers leveraged 45,856 de-identified chest CT screening cases and validated the results with a second dataset and also compared their results against six US board-certified radiologists. They found that when using a single CT scan for diagnosis, their model performed on par or better than the six radiologists and detected 5% more cancer cases while reducing false-positive exams by more than 11% as compared to unassisted radiologists in the study. Google’s approach achieved an AUC (a common metric used in machine learning that provides an aggregate measure for classification performance) of 94.4%.

With only 2-4% of eligible patients in the US being currently screened for lung cancer, Google’s research demonstrates the potential for AI to increase accuracy as well as consistency, which could help accelerate the adoption of lung cancer screening globally. Google now plans to conduct further studies to assess its impact and utility in clinical practice. It is collaborating with Google Cloud Healthcare and Life Sciences team to serve the model through the Cloud Healthcare API and is holding discussions with its partners across the world to continue additional clinical validation research and deployment.

Related Links:
Google


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.